Back | Next |
home / stock / coll / coll message board
Subject | By | Source | When |
---|---|---|---|
SHORT SQUEEZE - with 3M shorts outstanding & | floblu14 | investorshub | 11/07/2022 8:34:38 PM |
Say what? Upcoming clinical trial? Might be a | floblu14 | investorshub | 10/26/2022 6:09:17 PM |
Collegium Announces 11 Poster Presentations at PAINWeek 2022 | floblu14 | investorshub | 08/30/2022 12:26:56 PM |
Collegium Pharmaceutical, Inc. ($COLL) CEO Joseph Ciaffoni on | floblu14 | investorshub | 08/07/2022 1:12:28 PM |
Feel good? LOL | floblu14 | investorshub | 08/05/2022 6:25:47 PM |
Is $COLL next? Again, why did Colleen Tupper | floblu14 | investorshub | 07/28/2022 3:51:20 PM |
7 sale positions listed of which 4 are | floblu14 | investorshub | 07/27/2022 3:05:03 PM |
Reading between the lines - I'm guessing that | floblu14 | investorshub | 07/24/2022 1:01:35 PM |
New $COLL administer as of May 2022 - | floblu14 | investorshub | 07/11/2022 8:38:57 PM |
Is the Options Market Predicting a Spike in | floblu14 | investorshub | 07/06/2022 5:39:31 PM |
Collegium Pharmaceutical: Oversold And Cheap | floblu14 | investorshub | 06/15/2022 1:25:09 PM |
Needham Thinks Collegium Pharmaceuticals Stock is Going to Recover | floblu14 | investorshub | 05/11/2022 11:36:37 AM |
Collegium Pharmaceutical ($COLL) Received its Third Buy in | floblu14 | investorshub | 04/14/2022 11:24:59 AM |
AGAIN - | floblu14 | investorshub | 03/27/2022 1:54:28 PM |
Thomas B. Smith, M.D., FAAFP | floblu14 | investorshub | 03/23/2022 3:37:20 PM |
Hey, hey, HEY - | floblu14 | investorshub | 03/23/2022 11:05:13 AM |
ELYXYB home page - | floblu14 | investorshub | 03/22/2022 9:46:38 PM |
As of tomorrow - March 22 - A | floblu14 | investorshub | 03/21/2022 12:40:04 PM |
28 new career positions listed now after restructuring | floblu14 | investorshub | 03/09/2022 4:35:49 PM |
Talk about insider info/trades prior to quarterly earnings | floblu14 | investorshub | 02/28/2022 10:24:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
STOUGHTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced it has entered into an authorized generic ...
STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024...
STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has ...